| 6NY4: reference: Discovery of a JAK1/3 Inhibitor and Use of a Prodrug To Demonstrate Efficacy in a Model of Rheumatoid Arthritis., Spergel SH, Mertzman ME, Kempson J, Guo J, Stachura S, Haque L, Lippy JS, Zhang RF, Galella M, Pitt S, Shen G, Fura A, Gillooly K, McIntyre KW, Tang V, Tokarski J, Sack JS, Khan J, Carter PH, Barrish JC, Nadler SG, Salter-Cid LM, Schieven GL, Wrobleski ST, Pitts WJ, ACS Med Chem Lett. 2019 Feb 13;10(3):306-311. doi:, 10.1021/acsmedchemlett.8b00508. eCollection 2019 Mar 14. PMID: 30891131 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).